JP2015521848A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521848A5
JP2015521848A5 JP2015520569A JP2015520569A JP2015521848A5 JP 2015521848 A5 JP2015521848 A5 JP 2015521848A5 JP 2015520569 A JP2015520569 A JP 2015520569A JP 2015520569 A JP2015520569 A JP 2015520569A JP 2015521848 A5 JP2015521848 A5 JP 2015521848A5
Authority
JP
Japan
Prior art keywords
cell
protein
seq
nucleic acid
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015521848A (ja
JP6067849B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/048571 external-priority patent/WO2014005019A2/en
Publication of JP2015521848A publication Critical patent/JP2015521848A/ja
Publication of JP2015521848A5 publication Critical patent/JP2015521848A5/ja
Application granted granted Critical
Publication of JP6067849B2 publication Critical patent/JP6067849B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520569A 2012-06-29 2013-06-28 組換えイズロン酸２スルファターゼを製造するための細胞 Active JP6067849B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261666719P 2012-06-29 2012-06-29
US61/666,719 2012-06-29
PCT/US2013/048571 WO2014005019A2 (en) 2012-06-29 2013-06-28 Cells for producing recombinant iduronate-2-sulfatase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016052380A Division JP6302499B2 (ja) 2012-06-29 2016-03-16 組換えイズロン酸２スルファターゼを製造するための細胞

Publications (3)

Publication Number Publication Date
JP2015521848A JP2015521848A (ja) 2015-08-03
JP2015521848A5 true JP2015521848A5 (https=) 2016-01-07
JP6067849B2 JP6067849B2 (ja) 2017-01-25

Family

ID=49778522

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015520569A Active JP6067849B2 (ja) 2012-06-29 2013-06-28 組換えイズロン酸２スルファターゼを製造するための細胞
JP2016052380A Active JP6302499B2 (ja) 2012-06-29 2016-03-16 組換えイズロン酸２スルファターゼを製造するための細胞
JP2018037376A Active JP6755272B2 (ja) 2012-06-29 2018-03-02 組換えイズロン酸２スルファターゼを製造するための細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016052380A Active JP6302499B2 (ja) 2012-06-29 2016-03-16 組換えイズロン酸２スルファターゼを製造するための細胞
JP2018037376A Active JP6755272B2 (ja) 2012-06-29 2018-03-02 組換えイズロン酸２スルファターゼを製造するための細胞

Country Status (27)

Country Link
US (3) US9150841B2 (https=)
EP (1) EP2874649B1 (https=)
JP (3) JP6067849B2 (https=)
KR (1) KR101710487B1 (https=)
CN (2) CN107267460A (https=)
AU (3) AU2013282400B2 (https=)
BR (1) BR112014032560B1 (https=)
CA (1) CA2877521C (https=)
CL (1) CL2014003568A1 (https=)
CO (1) CO7240394A2 (https=)
CR (1) CR20140586A (https=)
DO (1) DOP2014000298A (https=)
EA (2) EA202090805A1 (https=)
ES (1) ES2718346T3 (https=)
GT (1) GT201400302A (https=)
HK (1) HK1209331A1 (https=)
IL (3) IL236343A (https=)
MX (2) MX336716B (https=)
MY (2) MY189314A (https=)
NZ (2) NZ734670A (https=)
PE (1) PE20150957A1 (https=)
PH (2) PH12016500011B1 (https=)
SG (2) SG10201509397SA (https=)
TR (1) TR201904435T4 (https=)
UA (1) UA118955C2 (https=)
WO (1) WO2014005019A2 (https=)
ZA (1) ZA201409396B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
RU2013120302A (ru) 2010-10-01 2014-11-20 Модерна Терапьютикс, Инк. Сконструированные нуклеиновые кислоты и способы их применения
EP2691101A2 (en) 2011-03-31 2014-02-05 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
CN104114572A (zh) 2011-12-16 2014-10-22 现代治疗公司 经修饰的核苷、核苷酸和核酸组合物
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
AU2013243948A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
WO2013166339A1 (en) * 2012-05-02 2013-11-07 Life Technologies Corporation High yield transient expression in mammalian cells using unique pairing of high density growth and transfection medium and expression enhancers
US9150841B2 (en) * 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US20140004097A1 (en) * 2012-06-29 2014-01-02 Shire Human Genetic Therapies, Inc. Method of producing recombinant iduronate-2-sulfatase
US9512456B2 (en) 2012-08-14 2016-12-06 Modernatx, Inc. Enzymes and polymerases for the synthesis of RNA
WO2014081507A1 (en) 2012-11-26 2014-05-30 Moderna Therapeutics, Inc. Terminally modified rna
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
EP2971010B1 (en) 2013-03-14 2020-06-10 ModernaTX, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
US9550972B2 (en) 2014-09-29 2017-01-24 General Electric Company Devices, systems and methods for automated cell culturing
EP3101125A1 (en) * 2015-06-05 2016-12-07 Laboratorios Del Dr. Esteve, S.A. Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
AU2016336344A1 (en) 2015-10-05 2018-04-19 Modernatx, Inc. Methods for therapeutic administration of messenger ribonucleic acid drugs
AU2018345303B2 (en) 2017-10-02 2025-09-18 Denali Therapeutics Inc. Fusion proteins comprising enzyme replacement therapy enzymes
JP7060235B2 (ja) * 2018-05-18 2022-04-26 国立大学法人広島大学 変異型イズロン酸－２－スルファターゼの機能回復薬剤のスクリーニング方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK6488D0 (da) 1988-01-07 1988-01-07 Novo Industri As Enzymer
US5310646A (en) 1988-05-13 1994-05-10 Regents Of The University Of Minnesota Method for the detection of mucopolysaccharide storage diseases
US5932211A (en) 1991-11-12 1999-08-03 Women's And Children's Hospital Glycosylation variants of iduronate 2-sulfatase
EP0750511B1 (en) 1994-03-16 2003-06-11 The Regents Of The University Of California Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
US5863782A (en) 1995-04-19 1999-01-26 Women's And Children's Hospital Synthetic mammalian sulphamidase and genetic sequences encoding same
DE19527054A1 (de) 1995-07-26 1997-01-30 Behringwerke Ag Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
EP1482031B1 (en) 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
WO2001018022A1 (en) 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 human secreted proteins
US7368531B2 (en) 1997-03-07 2008-05-06 Human Genome Sciences, Inc. Human secreted proteins
EP2301947A3 (en) 1999-02-26 2011-11-23 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
US7083793B2 (en) 1999-02-26 2006-08-01 Millennium Pharmaceuticals, Inc. Tango 243 polypeptides and uses thereof
IL145893A0 (en) 1999-04-26 2002-07-25 Genentech Inc Cell culture process for glycoproteins
JP2002017376A (ja) 1999-07-08 2002-01-22 Herikkusu Kenkyusho:Kk 分泌蛋白質、または膜蛋白質
US6780627B1 (en) 2000-01-31 2004-08-24 Millennium Pharmaceuticals, Inc. 22438, 23553, 25278, and 26212 novel human sulfatases
AU2001238488A1 (en) 2000-02-17 2001-08-27 Incyte Genomics, Inc. Human kinases
EP1268541A1 (en) 2000-03-17 2003-01-02 Human Genome Sciences, Inc. 7 human ovarian and ovarian cancer associated proteins
EP2206720A1 (en) 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
US20030148920A1 (en) 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
AU2002317700A1 (en) 2001-06-07 2002-12-16 Hemebiotech A/S Production of recombinant human arylsulfatase a
CA2478925C (en) 2002-04-26 2016-06-07 Robert Lee Fahrner Non-affinity purification of proteins
US6890736B1 (en) 2002-09-20 2005-05-10 Immunex Corporation Methods for producing proteins in cultured cells
CN101857851A (zh) 2002-12-23 2010-10-13 布里斯托尔-迈尔斯斯奎布公司 用于蛋白质生产的哺乳动物细胞培养方法
EP2325301B1 (en) 2003-02-11 2015-09-02 Shire Human Genetic Therapies, Inc. Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE)
US20050019914A1 (en) 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
WO2005113765A2 (en) 2004-05-06 2005-12-01 Biomarin Pharmaceutical Inc. Methods of activation of sulfatases and methods and compositions of using the same
EP2267024B1 (en) 2005-06-03 2012-05-09 Ares Trading S.A. Production of recombinant Il-18 binding protein
WO2007108955A1 (en) 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
CN105274072A (zh) 2008-01-18 2016-01-27 生物马林药物股份有限公司 制备活性高度磷酸化人溶酶体硫酸酯酶及其应用
JP2013507131A (ja) 2009-10-09 2013-03-04 アーメイゲン・テクノロジーズ・インコーポレイテッド Ｃｎｓにおけるイズロン酸２−スルファターゼ活性を増加させるための方法および組成物
KR20120093202A (ko) * 2009-10-09 2012-08-22 다우 글로벌 테크놀로지스 엘엘씨 단열식 플러그 흐름 반응기 및 염화 및/또는 불화 프로펜 및 고급 알켄의 제조 방법
JPWO2011108451A1 (ja) 2010-03-01 2013-06-27 日本ケミカルリサーチ株式会社 遺伝子ノックアウト細胞を用いた組換え体リソソーム酵素の製造方法
CN103179980B (zh) 2010-06-25 2016-09-28 夏尔人类遗传性治疗公司 艾杜糖醛酸-2-硫酸酯酶的cns递送的方法和组合物
WO2012101671A1 (en) 2011-01-25 2012-08-02 Jcr Pharmaceuticals Co., Ltd. Method for production of human recombinant iduronate 2-sulfatase
KR101158673B1 (ko) * 2011-06-24 2012-07-03 주식회사 지씨바이오 재조합 인간 이듀로네이트-2-설파타아제를 포함하는 조성물, 제제 및 이의 제조방법
US20140004097A1 (en) 2012-06-29 2014-01-02 Shire Human Genetic Therapies, Inc. Method of producing recombinant iduronate-2-sulfatase
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US9150841B2 (en) * 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase

Similar Documents

Publication Publication Date Title
JP2015521848A5 (https=)
JP2016105737A5 (https=)
WO2011012725A8 (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
MX366910B (es) Metodos de fabricacion para controlar el contenido de lisina c-terminal, galactosa y acido sialico en proteinas recombinantes.
JP2014524241A5 (https=)
EA201490631A1 (ru) Способы культивирования клеток млекопитающих для получения белка
EA201001435A1 (ru) Клетка, ферментирующая сахар-пентозу
NZ605403A (en) Method of producing recombinant adamts13 in cell culture
NZ602958A (en) High level expression of recombinant toxin proteins
WO2011091350A3 (en) Methods & compositions for improving protein production
JP2013545491A5 (https=)
WO2008126784A1 (ja) グルタチオンおよびγ-グルタミルシステインの製造法
MY166220A (en) Rabies virus like particle production in plants
JP2014076042A5 (https=)
CN106754447B (zh) 重组酿酒酵母及其在合成丙谷二肽中的应用
JP2016513457A5 (https=)
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
PH12014500640A1 (en) Increasing virus-like particle yield in plants
JP2020506722A5 (https=)
MX2019000075A (es) Metodo para la produccion fermentativa de moleculas de interes por microorganismos que comprenden genes que codifican el sistema de fosfotransferasa de azucar (pts).
IN2014DN00094A (https=)
CN104561076B (zh) 一种高产l‑丝氨酸重组谷氨酸棒杆菌的构建及其发酵方法
JP2021529527A5 (https=)
CN107287144A (zh) 一种代谢改造的枯草芽孢杆菌生物转化细胞及其制备方法与应用
CN105368808A (zh) 一种IdeS蛋白酶、其制备方法及应用